Toripalimab (anti-PD-1) versus high-dose interferon-α2b as adjuvant therapy in resected mucosal melanoma: a phase II randomized trial.
Lian B, Si L, Chi ZH, Sheng XN, Kong Y, Wang X, Tian H, Li K, Mao LL, Bai X, Tang BX, Yan XQ, Li SM, Zhou L, Dai J, Tang XW, Ran FW, Yao S, Guo J, Cui CL.
Lian B, et al. Among authors: cui cl.
Ann Oncol. 2022 Oct;33(10):1061-1070. doi: 10.1016/j.annonc.2022.07.002. Epub 2022 Jul 14.
Ann Oncol. 2022.
PMID: 35842199
Free article.
Clinical Trial.